Intravitreal Pegaptanib in Treatment of Choroidal Neovascularisation Secondary to Pathologic Myopia

Summary

Intravitreal pegaptanib for treatment of choroidal neovascularisation secondary to pathologic myopia

Timeline

Start

2010-12

Primary completion

2012-07

Completion

2012-07

Outcome

Outcome not reported

Stopped (Business): “Funding did not come through as the product was sold to another company.”

Drugs

Indications